Liu, D., M.A. Conant, M.J. Cowan, J. Laurence, C. Eden, E. Dunn, B.E. Thalenfeld, and D.L. Engelhardt. 2002. Engraftment and development of HGTV43-transduced CD34+ PBSC in HIV-1 seropositive individuals. Molecular Therapy 5:778A

Gotsman, I., R. Alper, A. Klein, E. Rabbani, D.L. Engelhardt, and Y. Ilan 2001. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice. Cancer 94:406-414.

Liu, D., Q. Wu, E. Dunn, C. Eden, M.J. Cowan, M.A. Conant, J.C. Laurence, B.E. Thalenfeld, and D.L. Engelhardt. 2001. In vivo maturation of U1/anti-HIV-1 antisense RNA-expressing CD4+ cells from transduced CD34+ PBSC in HIV-1 seropositive individuals. Molecular Therapy 3:870A

Liu, D., Q. Wu, J. Ng, E. Crisuolo, E. Felix, S. Chu, E. Wren, M. Cowan, C. Eden, M. Conant, B. Thalenfeld, and D. L. Engelhardt. 2001. Successful engraftment of transduced CD34+ cells and continued expression of genes encoding anti-HIV-1 antisense RNA in HIV-1 infected human subjects. 8th Conference on Retroviruses and Opportunistic Infections, Chicago, IL. Abstract 353.

Shlomai, A., S. Trop, I. Gotsman, O. Jurim, J. Diment, R. Alper, E. Rabbani, D.L. Engelhardt, and Y. Ilan. 2001. Immunomodulation of experimental colitis: the role of NK1.1 liver lymphocytes and surrogate antigens – bystander effect. J. Pathol. 195:498-507.

Brown, J.J., B. Parashar, H. Moshage, K. E. Tanaka, D.L. Engelhardt, E. Rabbani, N. Roy Chowdhury, and J. Roy Chowdhury. 2000. A long-term hepatitis B viremia model generated by transplanting nontumorigenic immortalized human hepatocytes in rag-2-deficient mice. Hepatology 31:173-181.

Brown, J.J., B. Parashar, A. Singh, E. Rabbani, D.L. Engelhardt, N. Roy-Chowdhury, and J. Roy-Chowdhury 2000. Oral tolerization to hepatitis B virus proteins ameliorates hepatic inflammation in Tupaia carrying hepatitis B viral infection. Hepatology 32:393A.

Gotsman, I., R. Beinart, R. Alper, E. Rabbani, D. L. Engelhardt, and Y. Ilan. 2000. Induction of oral tolerance towards hepatitis B envelope antigens in a murine model. Antiviral Res. 48:17-26.

Ilan, Y., I. Gotsman, M. Pines, R. Beinhart, M. Zeira, M. Chana, E. Rabbani, D. L. Engelhardt, and A. Nagler 2000. Induction of oral tolerance in splenocyte recipients toward pretransplant antigens ameliorates chronic graft versus host disease in a murine model. Blood 95:3613-3619.

Ilan Y., S. Weksler-Zangen, S. Ben-Horin, J. Diment, B. Sauter, E. Rabbani, D. L. Engelhardt, N. Roy Chowdhury, J. Roy Chowdhury, and E. Goldin. 2000. Treatment of experimental colitis by oral tolerance induction: a central role for suppressor lymphocytes. Amer. J. Gastroenterol. 95:966-973.

Nagler, A., M. Pines, U. Abadi, O. Pappo, M. Zeira, D.L. Engelhardt, E. Rabbani, and Y. Ilan. 2000. Oral tolerization ameliorates liver disorders associated with graft versus host disease in mice. Hepatology 31:641-648.

Safadi, R., E. Israeli, O. Pappo, I. Gotrsman, A. Klein, R. Alper, M. Rowe, B.E. Thalenfeld, D. L. Engelhardt, E. Rabbani, and Y. Ilan. 2000. Oral immunemodulation towards hepatitis B virus proteins – a new mode of treatment for chronic HBV infection: Results of a Phase I clinical trial. Hepatology 32:379A.

Brown, J.J., B. Parashar, D.L. Engelhardt, G. Nuovo, E. Rabbani, and Roy-Chowdhury. 1999. Oral tolerization therapy for HBV hepatitis in Tupaia belangeri. Third International Conference on Therapies for Viral Hepatitis, Maui, HI. Abstract

Gotsman, I., D. Samsonov, S. Trop, O. Jurim, R. Alper, J. Diment, D.L. Engelhardt, E. Rabbani, and Y. Ilan. 1999. Liver-mediated immunomodulation in a murine model: The role of NK1.1+ liver associated lymphocytes in peripheral tolerance induction.

Liu, D., J. Donegan, G. Nuovo, D. Mitra, and J. Laurence 1997. Stable human immunodeficiency virus type 1 (HIV-1) resistance in transformed CD4+ monocytic cells treated with multitargeting HIV-1 antisense sequences incorporated into U1 snRNA. Journal of Virology 71:4079-4085.